Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, α-phthalimidopropiophenone and N-ethylcathinone

Andrew Camilleri, Martin Johnston, Michael Brennan, Sean Davis, David Caldicott

    Research output: Contribution to journalArticle

    82 Citations (Scopus)

    Abstract

    In August 2007, four capsules containing white powders, said to have originated from an Israel-based Internet company " Neorganics" , were anonymously delivered to the Royal Adelaide Hospital, South Australia. The capsules were analysed and the active components were identified including 4-methylmethcathinone, 2-fluoromethamphetamine, α-phthalimidopropiophenone and N-ethylcathinone, all of which were unlisted within South Australian controlled substance regulations. We examined the relevant scientific literature surrounding these chemicals and present both GCMS and NMR data for 4-methylmethcathinone and α-phthalimidopropiophenone, which have previously received little attention. We also present the vapour- and condensed-phase infrared spectra (IR) of 4-methylmethcathinone as these have also not been reported in the literature previously. We discuss the issues surrounding whether these chemicals can be classified as controlled substance analogues and the likely impact this could have on prosecutions of individuals distributing these products.

    Original languageEnglish
    Pages (from-to)59-66
    Number of pages8
    JournalForensic Science International
    Volume197
    Issue number1-3
    DOIs
    Publication statusPublished - Apr 2010

    Keywords

    • α-Phthalimidopropiophenone
    • 2-Fluoromethamphetamine
    • 4-Methylmethcathinone
    • Analogue
    • Designer drugs
    • N-Ethylcathinone

    Fingerprint Dive into the research topics of 'Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, α-phthalimidopropiophenone and N-ethylcathinone'. Together they form a unique fingerprint.

  • Cite this